Home

鍔 Rezavý podstatné jméno acs med chem lett konzervativní Baron sekundární

Artificial Intelligence in Drug Design—The Storm Before the Calm? | ACS Medicinal Chemistry Letters
Artificial Intelligence in Drug Design—The Storm Before the Calm? | ACS Medicinal Chemistry Letters

Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors | ACS Medicinal Chemistry Letters
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors | ACS Medicinal Chemistry Letters

Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice | ACS Medicinal Chemistry Letters
Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice | ACS Medicinal Chemistry Letters

Discovery of Potent Deuterated Compounds as Potential KRASG12D Inhibitors in Cancer Therapy | ACS Medicinal Chemistry Letters
Discovery of Potent Deuterated Compounds as Potential KRASG12D Inhibitors in Cancer Therapy | ACS Medicinal Chemistry Letters

Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series | ACS Medicinal Chemistry Letters
Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series | ACS Medicinal Chemistry Letters

An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters | ACS Medicinal Chemistry Letters
An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters | ACS Medicinal Chemistry Letters

Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands | ACS Medicinal Chemistry Letters
Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands | ACS Medicinal Chemistry Letters

Structural and Functional Characterization of Indane-Core CD4-Mimetic Compounds Substituted with Heterocyclic Amines | ACS Medicinal Chemistry Letters
Structural and Functional Characterization of Indane-Core CD4-Mimetic Compounds Substituted with Heterocyclic Amines | ACS Medicinal Chemistry Letters

Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors | ACS Medicinal Chemistry Letters
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors | ACS Medicinal Chemistry Letters

Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design | ACS Medicinal Chemistry Letters
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design | ACS Medicinal Chemistry Letters

Addition of Fluorine and a Late-Stage Functionalization (LSF) of the Oral SERD AZD9833 | ACS Medicinal Chemistry Letters
Addition of Fluorine and a Late-Stage Functionalization (LSF) of the Oral SERD AZD9833 | ACS Medicinal Chemistry Letters

Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1) | ACS Medicinal Chemistry Letters
Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1) | ACS Medicinal Chemistry Letters

Systematic Study of Effects of Structural Modifications on the Aqueous Solubility of Drug-like Molecules | ACS Medicinal Chemistry Letters
Systematic Study of Effects of Structural Modifications on the Aqueous Solubility of Drug-like Molecules | ACS Medicinal Chemistry Letters

Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors | ACS Medicinal Chemistry Letters
Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors | ACS Medicinal Chemistry Letters

Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35 | ACS Medicinal Chemistry Letters
Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35 | ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters | Vol 11, No 11
ACS Medicinal Chemistry Letters | Vol 11, No 11

Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents | ACS Medicinal Chemistry Letters
Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents | ACS Medicinal Chemistry Letters

GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family | ACS Medicinal Chemistry Letters
GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family | ACS Medicinal Chemistry Letters

Author Guidelines
Author Guidelines

Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4 | ACS Medicinal Chemistry Letters
Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4 | ACS Medicinal Chemistry Letters

Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C | ACS Medicinal Chemistry Letters
Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C | ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters: Volume 11, Issue 5
ACS Medicinal Chemistry Letters: Volume 11, Issue 5

Design, Synthesis, and Anti-HBV Activity of New Bis(l-amino acid) Ester Tenofovir Prodrugs | ACS Medicinal Chemistry Letters
Design, Synthesis, and Anti-HBV Activity of New Bis(l-amino acid) Ester Tenofovir Prodrugs | ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters | Ahead of Print
ACS Medicinal Chemistry Letters | Ahead of Print

Relevance of the Trillion-Sized Chemical Space “eXplore” as a Source for Drug Discovery | ACS Medicinal Chemistry Letters
Relevance of the Trillion-Sized Chemical Space “eXplore” as a Source for Drug Discovery | ACS Medicinal Chemistry Letters

Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition | ACS Medicinal Chemistry Letters
Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition | ACS Medicinal Chemistry Letters

Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors | ACS Medicinal Chemistry Letters
Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors | ACS Medicinal Chemistry Letters